Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?
Background and aim. DNA methylation plays a critical role in the control of important cellular processes. The present study assessed the impact of promoter methylation (PM) of some genes on the antiviral response to antiviral therapy and it’s relation to the presence of fibrosis in HCV-4 infected pa...
Main Authors: | Abdel-Rahman N. Zekri, M.Sc., Ph.D., Ahmed M. Raafat, Suzan Elmasry, Abeer A. Bahnassy, Yasmin Saad, Hamed A. Dabaon, Mohamed El-Kassas, Hend I. Shousha, Auhood A. Nassar, Mohamed Ale EL-Dosouky, Nehal Hussein |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-09-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119312517 |
Similar Items
-
New era for management of chronic hepatitis C virus using direct antiviral agents: A review
by: Tamer Elbaz, et al.
Published: (2015-05-01) -
Impact of different anti-HCV regimens on platelet count during treatment in Egyptian patients
by: Sara Abd El Ghany, et al.
Published: (2020-09-01) -
Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients
by: Abdel-Rahman Zekri, et al.
Published: (2013-09-01) -
New therapies on the horizon for hepatitis C
by: Silvia C Sookoian, MD
Published: (2003-10-01) -
Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus
by: Youssif Bahaa G. M., et al.
Published: (2016-06-01)